Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.5 Form of Certificate of Domestication of Health Sciences Acquisitions Corporation 2, to Be Filed with the Secretary of State of Delaware
- 4.3 Specimen Common Stock Certificate of Orchestra Biomed Holdings, Inc
- 5.1 Opinion of Loeb & Loeb LLP
- 10.21 Form of Stock Option Grant Notice and Stock Option Agreement Under the Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 10.22 Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement Under the Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm of Health Sciences Acquisitions Corporation 2
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Orchestra Biomed, Inc
- 99.8 Form of Proxy Card for Health Sciences Acquisitions Corporation 2 Extraordinary General Meeting
- Download Excel data file
- View Excel data file
Associated filings
- 19 Dec 22 EFFECT Notice of effectiveness
- 16 Dec 22 424B3 Prospectus supplement
-
12 Dec 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Aug 22 S-4 Registration of securities issued in business combination transactions
OBIO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 4 to Form S-4 of our report dated March 31, 2022 relating to the financial statements of Health Sciences Acquisitions Corporation 2, which is contained in that Prospectus. We also consent to the reference to our Firm under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC | |
WithumSmith+Brown, PC |
New York, New York
December 12, 2022
WithumSmith+Brown, PC 1411 Broadway, 9th Floor, New York, New York 10018-3496 T (212) 7519100 F (212) 7503262 withum.com
AN INDEPENDENT MEMBER OF HLB - THE GLOBAL ADVISORY AND ACCOUNTING NETWORK